Featured Research

from universities, journals, and other organizations

Study Documents Initial Differences In Sexual Transmission Of HIV Between Males And Females

Date:
March 3, 2005
Source:
Johns Hopkins Medical Institutions
Summary:
A genetic analysis of viral RNA from 10 heterosexual couples, in which one partner has sexually transmitted HIV to the other, provides the first documentation of some differences in how the virus infects males and females.

A genetic analysis of viral RNA from 10 heterosexual couples, in which one partner has sexually transmitted HIV to the other, provides the first documentation of some differences in how the virus infects males and females. According to the Hopkins researchers who led the study, this initial research is essential to understanding why these differences occur and for future development of a vaccine or other preventive methods that could stop sexual transmission of HIV-1.

The couples in the study come from the Rakai Cohort, a Uganda-based population in a long-term study of HIV infection. The researchers tested each couple's viral RNA to determine which variants, or kinds of HIV-1 strain, were present in each man and woman. Variants of HIV-1 can be distinguished by differences in the gene (gp160) for their protein envelope. The findings showed that only a subset of HIV-1 variants in the initially infected partner was transmitted to the newly infected partner, and the predominant variant in males was not the kind that infected their female partners. And, women infected by men had a greater number of variants than men infected by women.

The selection of HIV-1 during sexual transmission: differences in gp160 diversity in male-to-female versus female-to-male transmission. Oliver Laeyendecker, Jordyn Gamiel, James Shepard, Xianbin Li, David Serwadda, Nelson Sewankambo, Fred Wabwire-Mangen, Francine McCutchan, Jonathan Toma, Wei Huang, Ronald Gray, Maria Wawer, and Thomas Quinn.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Study Documents Initial Differences In Sexual Transmission Of HIV Between Males And Females." ScienceDaily. ScienceDaily, 3 March 2005. <www.sciencedaily.com/releases/2005/02/050228122946.htm>.
Johns Hopkins Medical Institutions. (2005, March 3). Study Documents Initial Differences In Sexual Transmission Of HIV Between Males And Females. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2005/02/050228122946.htm
Johns Hopkins Medical Institutions. "Study Documents Initial Differences In Sexual Transmission Of HIV Between Males And Females." ScienceDaily. www.sciencedaily.com/releases/2005/02/050228122946.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins